[1] |
Zanelli M, Mengoli MC, Del Sordo R, et al. Intravascular NK/T⁃cell lymphoma, Epstein⁃Barr virus positive with multiorgan involvement: a clinical dilemma[J]. BMC Cancer, 2018,18(1):1115. doi: 10.1186/s12885⁃018⁃5001⁃6.
|
[2] |
徐嘉雯, 王宏量, 赵文博. 血管内NK/T细胞淋巴瘤的研究进展[J]. 临床与病理杂志, 2017,37(9):1932⁃1935. doi: 10.3978/j.issn.2095⁃6959.2017.09.028.
|
[3] |
Fonkem E, Lok E, Robison D, et al. The natural history of intravascular lymphomatosis[J]. Cancer Med, 2014,3(4):1010⁃1024. doi: 10.1002/cam4.269.
|
[4] |
Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO⁃EORTC classification for primary cutaneous lymphomas. Blood, 2019,133(16):1703⁃1714[J]. Blood, 2019,134(13):1112. doi: 10.1182/blood.2019002852.
|
[5] |
Cazzola M. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues[J]. Blood, 2016,127(20):2361⁃2364. doi: 10.1182/blood⁃2016⁃03⁃657379.
|
[6] |
Röglin J, Böer A. Skin manifestations of intravascular lymphoma mimic inflammatory diseases of the skin[J]. Br J Dermatol, 2007,157(1):16⁃25. doi: 10.1111/j.1365⁃2133.2007.07954.x.
|
[7] |
Choi YL, Park JH, Namkung JH, et al. Extranodal NK/T⁃cell lymphoma with cutaneous involvement: ′nasal′ vs. ′nasal⁃type′ subgroups⁃⁃a retrospective study of 18 patients[J]. Br J Dermatol, 2009,160(2):333⁃337. doi: 10.1111/j.1365⁃2133.2008. 08922.x.
|
[8] |
Liu Y, Zhang W, An J, et al. Cutaneous intravascular natural killer⁃cell lymphoma: a case report and review of the literature[J]. Am J Clin Pathol, 2014,142(2):243⁃247. doi: 10.1309/AJCP1JLYXLGDNOCH.
|
[9] |
Alegría⁃Landa V, Manzarbeitia F, Salvatierra Calderón MG, et al. Cutaneous intravascular natural killer/T cell lymphoma with peculiar immunophenotype[J]. Histopathology, 2017,71(6):994⁃1002. doi: 10.1111/his.13332.
|